BC
Blackcrane Capital Portfolio holdings
AUM
$16.3M
1-Year Return
19.53%
This Quarter Return
+8.57%
1 Year Return
-19.53%
3 Year Return
+33.91%
5 Year Return
–
10 Year Return
–
AUM
$50.9M
AUM Growth
+$8.07M
(+19%)
Cap. Flow
+$8.51M
Cap. Flow
% of AUM
16.7%
Top 10 Holdings %
Top 10 Hldgs %
98.74%
Holding
11
New
3
Increased
4
Reduced
4
Closed
–
Top Buys
| 1 |
Open Text
OTEX
|
+$6.9M |
| 2 |
PROF
Profound Medical
PROF
|
+$2.98M |
| 3 |
MYOV
Myovant Sciences Ltd.
MYOV
|
+$1.93M |
| 4 |
Neurocrine Biosciences
NBIX
|
+$1.1M |
| 5 |
Nice
NICE
|
+$218K |
Top Sells
| 1 |
Avita Medical
RCEL
|
+$3.09M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$1.58M |
| 3 |
Microsoft
MSFT
|
+$300K |
| 4 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
+$2.55K |
Sector Composition
| 1 | Technology | 51.2% |
| 2 | Healthcare | 48.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
WIX.com
WIX
$9.56B
| $10.6M | 20.79% |
42,363
+753
| +2% | +$188K |
|
|
2
Nice
NICE
$8.82B
| $7.58M | 14.87% |
26,721
+769
| +3% | +$218K |
|
|
PROF
3
Profound Medical
PROF
$121M
| $7.03M | 13.8% |
341,767
+144,843
| +74% | +$2.98M |
|
|
4
Open Text
OTEX
$9.07B
| $6.9M | 13.55% |
+151,800
| New | +$6.9M |
|
|
AXNX
5
DELISTED
Axonics, Inc. Common Stock
AXNX
| $6.23M | 12.23% |
124,736
-51
| -0% | -$2.55K |
|
|
6
Avita Medical
RCEL
$123M
| $5.73M | 11.25% |
308,504
-166,478
| -35% | -$3.09M |
|
|
BHVN
7
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $2.2M | 4.32% |
25,641
-18,471
| -42% | -$1.58M |
|
|
MYOV
8
DELISTED
Myovant Sciences Ltd.
MYOV
| $1.93M | 3.78% |
+69,695
| New | +$1.93M |
|
|
9
Neurocrine Biosciences
NBIX
$14.1B
| $1.1M | 2.16% |
+11,499
| New | +$1.1M |
|
|
10
Microsoft
MSFT
$3.79T
| $1.01M | 1.99% |
4,555
-1,349
| -23% | -$300K |
|
11
Takeda Pharmaceutical
TAK
$47.7B
| $641K | 1.26% |
35,236
+9,513
| +37% | +$173K |
|